Both in Biotechnology
Repligen vs Krystal Biotech
Over the past year RGEN returned +19.0% and KRYS returned +57.8%; their daily moves had a correlation of 0.26.
RGEN +19.0% KRYS +57.8%Growth of $1, one year, split-adjusted
| Metric | RGEN | KRYS |
|---|---|---|
| Price | $178.72 | $312.15 |
| Market cap | $11.35B | $9.24B |
| Today | +0.25% | +2.33% |
| 1 month | +2.2% | −4.5% |
| 6 months | +42.1% | +8.0% |
| Year to date | +9.1% | +26.6% |
| 1 year | +19.0% | +57.8% |
| Revenue growth (YoY) | +10.9% | +30.2% |
| Gross margin | 53.0% | 94.1% |
| Net margin | −18.4% | 49.5% |
| P/E (TTM) | — | 41.0× |
| Price / sales | 14.1× | 19.7× |
| Net cash | $307.4M | $911.9M |
| Dividend yield | — | — |
| Volatility (60d) | 47.3% | 39.2% |
| Short % of float | 12.8% | 12.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).